Lubiprostone Prevents Nonsteroidal Anti-Inflammatory Drug-Induced Small Intestinal Damage by Suppressing the Expression of Inflammatory Mediators via EP4

被引:31
作者
Hayashi, Shusaku [1 ]
Kurata, Naoto [1 ]
Yamaguchi, Aya [1 ]
Amagase, Kikuko [1 ]
Takeuchi, Koji [1 ,2 ]
机构
[1] Kyoto Pharmaceut Univ, Div Pathol Sci, Dept Pharmacol & Expt Therapeut, Misasagi, Yamashina, Japan
[2] Kyoto Res Ctr Gastrointestinal Dis, Gen Inc Assoc, Kyoto 6048106, Japan
关键词
DUODENAL BICARBONATE SECRETION; NITRIC-OXIDE SYNTHASE; RAT SMALL-INTESTINE; PROSTAGLANDIN E-2; UP-REGULATION; INDOMETHACIN; LESIONS; RECEPTORS; INHIBITION; ACTIVATION;
D O I
10.1124/jpet.114.213991
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Lubiprostone, a bicyclic fatty acid derived from prostaglandin E-1, has been used to treat chronic constipation and irritable bowel syndrome, and its mechanism of action has been attributed to the stimulation of intestinal fluid secretion via the activation of the chloride channel protein 2/cystic fibrosis transmembrane regulator (ClC-2/CFTR) chloride channels. We examined the effects of lubiprostone on indomethacin-induced enteropathy and investigated the functional mechanisms involved, including its relationship with the EP4 receptor subtype. Male Sprague-Dawley rats were administered indomethacin (10 mg/kg p.o.) and killed 24 hours later to examine the hemorrhagic lesions that developed in the small intestine. Lubiprostone (0.01-1 mg/kg) was administered orally twice 30 minutes before and 9 h after the indomethacin treatment. Indomethacin markedly damaged the small intestine, accompanied by intestinal hypermotility, a decrease in mucus and fluid secretion, and an increase in enterobacterial invasion as well as the up-regulation of inducible nitric-oxide synthase (iNOS) and tumor necrosis factor a (TNF alpha) mRNAs. Lubiprostone significantly reduced the severity of these lesions, with the concomitant suppression of the functional changes. The effects of lubiprostone on the intestinal lesions and functional alterations were significantly abrogated by the coadministration of AE3-208 [4-(4-cyano-2-(2-(4-fluoronaphthalen1- yl) propionylamino) phenyl) butyric acid], a selective EP4 antagonist, but not by CFTR(inh)-172, a CFTR inhibitor. These results suggest that lubiprostone may prevent indomethacin-induced enteropathy via an EP4 receptor-dependent mechanism. This effect may be functionally associated with the inhibition of intestinal hypermotility and increase in mucus/fluid secretion, resulting in the suppression of bacterial invasion and iNOS/ TNFa expression, which are major pathogenic events in enteropathy. The direct activation of CFTR/ClC-2 chloride channels is not likely to have contributed to the protective effects of lubiprostone.
引用
收藏
页码:470 / 479
页数:10
相关论文
共 44 条
  • [1] Involvement of prostaglandin E receptor EP3 subtype in duodenal bicarbonate secretion in rats
    Aihara, Eitaro
    Nomura, Yoko
    Sasaki, Yoko
    Ise, Fumitaka
    Kita, Kazutomo
    Takeuchi, Koji
    [J]. LIFE SCIENCES, 2007, 80 (26) : 2446 - 2453
  • [2] Protective effect of lafutidine, a histamine H2 receptor antagonist, against loxoprofen-induced small intestinal lesions in rats
    Amagase, Kikuko
    Ochi, Akimu
    Sugihara, Tetsuya
    Kato, Shinichi
    Takeuchi, Koji
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : S111 - S118
  • [3] A synthetic prostone activates apical chloride channels in A6 epithelial cells
    Bao, Hui Fang
    Liu, Lian
    Self, Julie
    Duke, Billie Jeanne
    Ueno, Ryuji
    Eaton, Douglas C.
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2008, 295 (02): : G234 - G251
  • [4] Activation of prostaglandin EP receptors by lubiprostone in rat and human stomach and colon
    Bassil, A. K.
    Borman, R. A.
    Jarvie, E. M.
    McArthur-Wilson, R. J.
    Thangiah, R.
    Sung, E. Z. H.
    Lee, K.
    Sanger, G. J.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2008, 154 (01) : 126 - 135
  • [5] Increase in tumor necrosis factor-α production linked to the toxicity of indomethacin for the rat small intestine
    Bertrand, V
    Guimbaud, R
    Tulliez, M
    Mauprivez, C
    Sogni, P
    Couturier, D
    Giroud, JP
    Chaussade, S
    Chauvelot-Moachon, L
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1998, 124 (07) : 1385 - 1394
  • [6] Activation of Intestinal Cl- Secretion by Lubiprostone Requires the Cystic Fibrosis Transmembrane Conductance Regulator
    Bijvelds, Marcel J. C.
    Bot, Alice G. M.
    Escher, Johanna C.
    de Jonge, Hugo R.
    [J]. GASTROENTEROLOGY, 2009, 137 (03) : 976 - 985
  • [7] THE INDUCTION OF NITRIC-OXIDE SYNTHASE AND INTESTINAL VASCULAR-PERMEABILITY BY ENDOTOXIN IN THE RAT
    BOUGHTONSMITH, NK
    EVANS, SM
    LASZLO, F
    WHITTLE, BJR
    MONCADA, S
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1993, 110 (03) : 1189 - 1195
  • [8] INVOLVEMENT OF ENDOGENOUS NITRIC-OXIDE IN THE REGULATION OF RAT INTESTINAL MOTILITY INVIVO
    CALIGNANO, A
    WHITTLE, BJR
    DIROSA, M
    MONCADA, S
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 229 (2-3) : 273 - 276
  • [9] SPI-0211 activates T84 cell chloride transport and recombinant human ClC-2 chloride currents
    Cuppoletti, J
    Malinowska, DH
    Tewari, KP
    Li, QJ
    Sherry, AM
    Patchen, ML
    Ueno, R
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2004, 287 (05): : C1173 - C1183
  • [10] Lubiprostone targets prostanoid EP4 receptors in ovine airways
    Cuthbert, A. W.
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 2011, 162 (02) : 508 - 520